March 8th, 2025: Vision Loss Allegations Lead Users to Pursue Legal Action Lawsuits continue to grow against the makers of GLP-1 medications like Ozempic, Mounjaro, and Wegovy, as patients report unexpected and irreversible vision problems
Semaglutide and the other GLP-1 agonists have the added benefit of central effects on the hunger centres in the hypothalamus as well as delaying gastric emptying to increase fullness and suppress appetite, a valuable tool for both the treatment of diabetes and weight loss management, but a potential risk for the use of sedation/anaesthesia
Regular body composition scans allow people to monitor fat and muscle changes while on a GLP-1 program
Furthermore, antihypertensive drugs that do not block the SNS may exhibit an increasing BP effect of DPP-4 inhibitors by lowering basal vascular tone (86)
BPC-157 reaches into the control panel and adjusts both dials simultaneously
Pharmaceutical manufacturers operate PAPs to help eligible patients access medications they otherwise couldnt afford